SimBioSys
Champaign
About SimBioSys
SimBioSys is developing a Computational Microscope that integrates state-of-the-art simulation techniques with a diverse set of experimental datasets to provide new insight into the behavior of cancers. The technology allows researchers to peer into the cancer microenvironment to identify the behavior of tumors: the cell phenotypes, how they interact with surrounding tissues, and how they prime their neighbors for invasion, all from the comfort of their computer desk.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2021)
- Website: simbiosys.com
- Phone: (217) 819-2022
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/simbiosys-51565 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.